Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. [PDF]
Pharmaceutics, 2023 García-Arieta A +4 more
europepmc +1 more source
Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Fexofenadine
29812993In this monograph, the potential use of methods based on the Biopharmaceutics Classification System (BCS) framework to evaluate the bioequivalence of solid immediate-release (IR) oral dosage forms containing fexofenadine hydrochloride as a ...
Langguth, Peter +11 more
core +1 more source
Foreign Comparator Drug Products, Manufacturing & Supply Chain Considerations for Otic, Ophthalmic, And Parenteral Solutions - Generic Drugs Perspective. [PDF]
AAPS JNana A +4 more
europepmc +1 more source
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). [PDF]
Pharmaceut Med, 2023 Moeti L, Litedu M, Joubert J.
europepmc +1 more source
Emerging perspectives on leveraging physiologically based biopharmaceutics modeling (PBBM) for BCS class III biowaivers: A webinar summary. [PDF]
J Pharm SciFang L +8 more
europepmc +1 more source
Editorial: The practical implication of clinical pharmacokinetics in drug development, pharmaceutical analysis, and clinical research. [PDF]
Front Pharmacol, 2023 Khan A, Ahmad L, Raza F, Khan SA, Ali T.
europepmc +1 more source
Predictive Potential of Acido-Basic Properties, Solubility and Food on Bioequivalence Study Outcome: Analysis of 128 Studies. [PDF]
Drugs R D, 2023 Krajcar D +4 more
europepmc +1 more source
Bioequivalence centres in Africa: current state and opportunities for growth. [PDF]
J Pharm Policy PractNcube BM, Muthuri S, Ajose O, Kikwai L.
europepmc +1 more source
Bioequivalence of a Generic Vortioxetine 20 mg Tablet in Healthy Mexican Volunteers Under Fasting Conditions. [PDF]
Pharmaceuticals (Basel)Cruz PC +5 more
europepmc +1 more source